Tamoxifen-induced hyperosmolar hyperglycemic state secondary to suspected pancreatic beta cell inflammation
Selective estrogen receptor modulators, such as tamoxifen, have been used for many years to reduce the recurrence of breast cancer. There is limited data on tamoxifen use in males with breast cancer. Hyperglycemia or risk of diabetes is not listed on the package insert for tamoxifen. In this clinica...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Current Problems in Cancer: Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666621920300077 |